Abingdon Health (LON:ABDX) Stock Jumps 5.6% – Here’s What Happened

Shares of Abingdon Health Plc (LON:ABDX) traded up 5.6% during mid-day trading on Wednesday. The company traded as high as GBX 9.50 and last traded at GBX 9.50. Approximately 12,604 shares changed hands during trading, a decline of 94% from the average session volume of 223,199 shares. The stock had previously closed at GBX 9.

Abingdon Health Trading Up 6.4%

The company has a debt-to-equity ratio of 21.99, a current ratio of 1.91 and a quick ratio of 1.96. The firm has a fifty day simple moving average of GBX 10.05 and a 200-day simple moving average of GBX 9.54. The firm has a market cap of £40.27 million, a P/E ratio of -18.15 and a beta of 0.13.

Abingdon Health (LON:ABDX) last issued its quarterly earnings data on Tuesday, October 13th. The company reported GBX (0.51) EPS for the quarter. Abingdon Health had a negative return on equity of 34.31% and a negative net margin of 19.36%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.